Recent studies have reported the overexpression of SPC25 in various tumors, including head and neck cancer, breast cancer, prostate cancer, lung cancer, hepatocellular carcinoma (HCC), colorectal cancer, and gastric cancer [48–54]. Here, SPC25 is linked to lung carcinoma.